{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:11:42Z","timestamp":1790698302115,"version":"4.1.0"},"reference-count":197,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Cardiovascular disease (CVD) is the leading cause of death worldwide, with pathophysiological mechanisms often involving platelet activation and chronic inflammation. While antiplatelet agents targeting adenosine diphosphate (ADP)-mediated pathways are well established in CVD management, less is known about drug interactions with the platelet-activating factor (PAF) pathway, a key mediator of inflammation. This study aimed to evaluate the effects of several commonly used cardiovascular and anti-inflammatory drug classes\u2014including clopidogrel, non-steroidal anti-inflammatory drugs (NSAIDs), angiotensin II receptor blockers (ARBs), \u03b2-blockers, and analgesics\u2014on platelet function via both the ADP and PAF pathways. Using human platelet-rich plasma (hPRP) from healthy donors, we assessed platelet aggregation in response to these two agonists in the absence and presence of graded concentrations of each of these drugs or of their usually prescribed combinations. The study identified differential drug effects on platelet aggregation, with some agents showing pathway-specific activity. Clopidogrel and NSAIDs demonstrated expected antiplatelet effects, while some (not all) antihypertensives exhibited additional anti-inflammatory potential. These findings highlight the relevance of evaluating pharmacological activity beyond traditional targets, particularly in relation to PAF-mediated inflammation and thrombosis. This dual-pathway analysis may contribute to a broader understanding of drug mechanisms and inform the development of more comprehensive therapeutic strategies for the prevention and treatment of cardiovascular, hypertension, and inflammation-driven diseases.<\/jats:p>","DOI":"10.3390\/medicina61081413","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T15:30:06Z","timestamp":1754321406000},"page":"1413","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anti-Inflammatory and Antiplatelet Interactions on PAF and ADP Pathways of NSAIDs, Analgesic and Antihypertensive Drugs for Cardioprotection\u2014In Vitro Assessment in Human Platelets"],"prefix":"10.3390","volume":"61","author":[{"given":"Makrina","family":"Katsanopoulou","sequence":"first","affiliation":[{"name":"Hephaestus Laboratory, School of Chemistry, Faculty of Sciences, Democritus University of Thrace, Kavala University Campus, St. Lucas, GR-65404 Kavala, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zisis","family":"Zannas","sequence":"additional","affiliation":[{"name":"Hephaestus Laboratory, School of Chemistry, Faculty of Sciences, Democritus University of Thrace, Kavala University Campus, St. Lucas, GR-65404 Kavala, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3925-6284","authenticated-orcid":false,"given":"Anna","family":"Ofrydopoulou","sequence":"additional","affiliation":[{"name":"Hephaestus Laboratory, School of Chemistry, Faculty of Sciences, Democritus University of Thrace, Kavala University Campus, St. Lucas, GR-65404 Kavala, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chatzikamari","family":"Maria","sequence":"additional","affiliation":[{"name":"Hematology and Internal Medicine Departments, General Hospital of Kavala, St. Silas, GR-65500 Kavala, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenophon","family":"Krokidis","sequence":"additional","affiliation":[{"name":"Hematology and Internal Medicine Departments, General Hospital of Kavala, St. Silas, GR-65500 Kavala, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra A.","family":"Lambropoulou","sequence":"additional","affiliation":[{"name":"Laboratory of Environmental Pollution Control, Department of Chemistry, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece"},{"name":"Center for Interdisciplinary Research and Innovation (CIRI-AUTH), Balkan Center, 10th km Thessaloniki-Thermi Rd, GR-57001 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0837-9778","authenticated-orcid":false,"given":"Alexandros","family":"Tsoupras","sequence":"additional","affiliation":[{"name":"Hephaestus Laboratory, School of Chemistry, Faculty of Sciences, Democritus University of Thrace, Kavala University Campus, St. Lucas, GR-65404 Kavala, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart Disease and Stroke Statistics\u20142018 Update: A Report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"ref_2","first-page":"41","article-title":"A Comprehensive Assessment of Mortality and Disability from Diesease, Injuries and Risk Factors in 1990 and Projected to 2020","volume":"1","author":"Murray","year":"1994","journal-title":"Glob. Burd. Dis."},{"key":"ref_3","unstructured":"World Health Organization (2002). The World Health Report 2002: Reducing Risks, Promoting Healthy Life, World Health Organization."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Waldstein, S.R., Kop, W.J., Suarez, E.C., Lovallo, W.R., and Katzel, L.I. (2022). Classification of Cardiovascular Diseases: Epidemiology, Diagnosis, and Treatment. Handbook of Cardiovascular Behavioral Medicine, Springer.","DOI":"10.1007\/978-0-387-85960-6"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0002-9149(92)90726-F","article-title":"Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study)","volume":"70","author":"Berenson","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1111\/bcp.15221","article-title":"Antiplatelet therapy in cardiovascular disease: Current status and future directions","volume":"88","author":"Passacquale","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"105823","DOI":"10.1016\/j.neuint.2024.105823","article-title":"Diet and Nutraceuticals for treatment and prevention of primary and secondary stroke: Emphasis on nutritional antiplatelet and antithrombotic agents","volume":"179","author":"Kakarla","year":"2024","journal-title":"Neurochem. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.2023020535","article-title":"Hemostasis without clot formation: How platelets guard the vasculature in inflammation, infection, and malignancy","volume":"142","author":"Kaiser","year":"2023","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Scridon, A. (2022). Platelets and Their Role in Hemostasis and Thrombosis\u2014From Physiology to Pathophysiology and Therapeutic Implications. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232112772"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Mussbacher, M., Kral-Pointner, J.B., Salzmann, M., Schrottmaier, W.C., and Assinger, A. (2019). Mechanisms of Hemostasis: Contributions of Platelets, Coagulation Factors, and the Vessel Wall. Fundamentals of Vascular Biology, Springer International Publishing.","DOI":"10.1007\/978-3-030-12270-6_8"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/asheducation-2010.1.387","article-title":"Understanding and Evaluating Platelet Function","volume":"2010","author":"Brass","year":"2010","journal-title":"Hematology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/asheducation-2009.1.267","article-title":"Antiplatelet agents","volume":"2009","author":"Varon","year":"2009","journal-title":"Hematology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1038\/sj.bjp.0706401","article-title":"Antiplatelet drugs","volume":"147","author":"Born","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","author":"Altman","year":"1994","journal-title":"BMJ"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/bmj.320.7240.991","article-title":"Secondary prevention of transient ischaemic attack and stroke","volume":"320","author":"Lees","year":"2000","journal-title":"BMJ"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"CAPRIE Steering Committee (1996). A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet, 348, 1329\u20131339.","DOI":"10.1016\/S0140-6736(96)09457-3"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/01.CIR.101.6.590","article-title":"A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents","volume":"101","author":"Petersen","year":"2000","journal-title":"Circulation"},{"key":"ref_18","first-page":"276","article-title":"Combination therapy with clopidogrel and aspirin after coronary stenting","volume":"50","author":"Kolansky","year":"2000","journal-title":"Cathet. Cardiovasc. Intervent."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/ar116","article-title":"Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs","volume":"2","author":"Steinmeyer","year":"2000","journal-title":"Arthritis Res. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"140148","DOI":"10.1016\/j.molstruc.2024.140148","article-title":"Insight on development of oxazole and imidazole derivatives as COX inhibitors with anti-inflammatory effects","volume":"1321","author":"Rayan","year":"2025","journal-title":"J. Mol. Struct."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/clpt.2011.45","article-title":"Cardiovascular and Gastrointestinal Safety of NSAIDs: A Systematic Review of Meta-Analyses of Randomized Clinical Trials","volume":"89","author":"Salvo","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/rth2.12283","article-title":"van der Not all (N)SAID and done: Effects of nonsteroidal anti-inflammatory drugs and paracetamol intake on platelets","volume":"4","author":"Driver","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Offermanns, S., and Rosenthal, W. (2021). el-Hady Antihypertensive Drugs. Encyclopedia of Molecular Pharmacology, Springer International Publishing.","DOI":"10.1007\/978-3-030-57401-7"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"(2000). Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Lancet, 355, 253\u2013259.","DOI":"10.1016\/S0140-6736(99)12323-7"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1161\/CIRCULATIONAHA.109.865774","article-title":"Effects of Telmisartan, Ramipril, and Their Combination on Left Ventricular Hypertrophy in Individuals at High Vascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease","volume":"120","author":"Verdecchia","year":"2009","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_27","first-page":"e362","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"Kushner","year":"2013","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_29","first-page":"e344","article-title":"2014 AHA\/ACC Guideline for the Management of Patients with Non\u2013ST-Elevation Acute Coronary Syndromes","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jacc.2005.09.055","article-title":"The Effect of Valsartan, Captopril, or Both on Atherosclerotic Events After Acute Myocardial Infarction","volume":"47","author":"McMurray","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: The OPTIMAAL randomised trial","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199808203390801","article-title":"Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction","volume":"339","author":"Gottlieb","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/eurjhf\/hfp001","article-title":"Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: Analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)","volume":"11","author":"Hawkins","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"MERIT-HF Study Group (1999). Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF). Lancet, 353, 2001\u20132007.","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure: Results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"f6650","DOI":"10.1136\/bmj.f6650","article-title":"Effect of \u03b2 blockers on mortality after myocardial infarction in adults with COPD: Population based cohort study of UK electronic healthcare records","volume":"347","author":"Quint","year":"2013","journal-title":"BMJ"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"d2549","DOI":"10.1136\/bmj.d2549","article-title":"Effect of beta blockers in treatment of chronic obstructive pulmonary disease: A retrospective cohort study","volume":"342","author":"Short","year":"2011","journal-title":"BMJ"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/00000542-200510000-00009","article-title":"Dose-dependent inhibition of platelet function by acetaminophen in healthy volunteers","volume":"103","author":"Munsterhjelm","year":"2005","journal-title":"Anesthesiology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.indcrop.2018.04.040","article-title":"Enhanced biosynthesis of colchicine and thiocolchicoside contents in cell suspension cultures of Gloriosa superba L. exposed to ethylene inhibitor and elicitors","volume":"120","author":"Mahendran","year":"2018","journal-title":"Ind. Crops Prod."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0014-2999(96)00884-9","article-title":"Interaction of thiocolchicoside with [3H]strychnine binding sites in rat spinal cord and brainstem","volume":"318","author":"Cimino","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Tsoupras, A., Lordan, R., and Zabetakis, I. (2018). Inflammation, not Cholesterol, Is a Cause of Chronic Disease. Nutrients, 10.","DOI":"10.3390\/nu10050604"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Tsoupras, A., Cholidis, P., Kranas, D., Galouni, E.A., Ofrydopoulou, A., Efthymiopoulos, P., Shiels, K., Saha, S.K., Kyzas, G.Z., and Anastasiadou, C. (2024). Anti-Inflammatory, Antithrombotic, and Antioxidant Properties of Amphiphilic Lipid Bioactives from Shrimp. Pharmaceuticals, 18.","DOI":"10.3390\/ph18010025"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Papadopoulou, D., Chrysikopoulou, V., Rampaouni, A., Plakidis, C., Ofrydopoulou, A., Shiels, K., Saha, S.K., and Tsoupras, A. (2025). Antioxidant, Antithrombotic and Anti-Inflammatory Properties of Amphiphilic Bioactives from Water Kefir Grains and Its Apple Pomace-Based Fermented Beverage. Antioxidants, 14.","DOI":"10.3390\/antiox14020164"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/bmj.290.6466.428","article-title":"Epidemiological Characteristics of Platelet Aggregability","volume":"290","author":"Meade","year":"1985","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mex.2018.12.012","article-title":"Platelet aggregometry assay for evaluating the effects of platelet agonists and antiplatelet compounds on platelet function in vitro","volume":"6","author":"Tsoupras","year":"2019","journal-title":"MethodsX"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/194927b0","article-title":"Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal","volume":"194","author":"Born","year":"1962","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1055\/s-0038-1661277","article-title":"Methods in dose response platelet aggregometry","volume":"53","author":"Thompson","year":"1985","journal-title":"Thromb. Haemost."},{"key":"ref_48","first-page":"345","article-title":"Re-Assessing the Role of Platelet Activating Factor and Its Inflammatory Signaling and Inhibitors in Cancer and Anti-Cancer Strategies","volume":"29","author":"Tsoupras","year":"2024","journal-title":"FBL"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejphar.2017.01.015","article-title":"Additive antithrombotic effect of ASP6537, a selective cyclooxygenase (COX)-1 inhibitor, in combination with clopidogrel in guinea pigs","volume":"798","author":"Sakata","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2325967115588896","DOI":"10.1177\/2325967115588896","article-title":"Autologous Platelet-Rich Plasma Preparations: Influence of Nonsteroidal Anti-inflammatory Drugs on Platelet Function","volume":"3","author":"Schippinger","year":"2015","journal-title":"Orthop. J. Sports Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2249.1992.tb03080.x","article-title":"Involvement of platelet-activating factor and tumour necrosis factor in the pathogenesis of joint inflammation in rabbits","volume":"88","author":"Zarco","year":"1992","journal-title":"Clin. Exp. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"23352","DOI":"10.1039\/C9RA01670H","article-title":"The aqueous extract of Olea europaea leaves protects from haematotoxicity and kidney damage induced by diclofenac in Swiss albino mice","volume":"9","author":"Soussi","year":"2019","journal-title":"RSC Adv."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Schmidt, L., Burmeister, L.S., Greinacher, A., K\u00f6nig, S., and Garscha, U. (2022). Development of SFC-MS Method for Quantification of Eicosanoids Biosynthesized in Primary Human Blood Cells. Metabolites, 12.","DOI":"10.3390\/metabo12121198"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"160","DOI":"10.21470\/1678-9741-2019-0283","article-title":"The Effect of Diclofenac on Bleeding, Platelet Function, and Consumption of Opioids Following Cardiac Surgery","volume":"35","author":"Osojnik","year":"2020","journal-title":"Braz. J. Cardiovasc. Surg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1399-6576.1997.tb04657.x","article-title":"Comparison of the effect of intravenous ketoprofen, ketorolac and diclofenac on platelet function in volunteers","volume":"41","author":"Niemi","year":"1997","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.26641\/2307-0404.2022.4.271171","article-title":"Comparative analysis of the effect of diclofenac sodium and etoricoxib on energy metabolism in rat liver in the acute general cooling model","volume":"27","author":"Koiro","year":"2022","journal-title":"Medicni Perspekt."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Dubrall, D., Just, K.S., Schmid, M., Stingl, J.C., and Sachs, B. (2020). Adverse drug reactions in older adults: A retrospective comparative analysis of spontaneous reports to the German Federal Institute for Drugs and Medical Devices. BMC Pharmacol. Toxicol., 21.","DOI":"10.1186\/s40360-020-0392-9"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4049\/jimmunol.1900599","article-title":"Platelets Modulate IFN-\u03b3 Production against Candida albicans in Peripheral Blood Mononuclear Cells via Prostaglandins","volume":"204","author":"Dewi","year":"2020","journal-title":"J. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00210-022-02218-2","article-title":"Inhibition of neurogenic contractions in renal arteries and of cholinergic contractions in coronary arteries by the presumed inhibitor of ADP-ribosylation factor 6, NAV2729","volume":"395","author":"Huang","year":"2022","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/2221-1691.335693","article-title":"Protein extract of kenaf seed exhibits anticoagulant, antiplatelet and antioxidant activities","volume":"12","author":"Hanumegowda","year":"2022","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2174\/1573412919666221223152915","article-title":"Metabolomics-based Approach to Analyze the Therapeutic Targets and Metabolites of a Synovitis Ointment for Knee Osteoarthritis","volume":"19","author":"Zhang","year":"2023","journal-title":"Curr. Pharm. Anal."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1023\/A:1027311713908","article-title":"Study on Paradoxical Effects of NSAIDs on Platelet Activation","volume":"21","author":"Andrioli","year":"1997","journal-title":"Inflammation"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00001721-199603000-00010","article-title":"Dual effects of diclofenac on human platelet adhesion in vitro","volume":"Volume 7","author":"Andrioli","year":"1996","journal-title":"Blood Coagulation & Fibrinolysis"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/j.1538-7836.2009.03582.x","article-title":"Prothrombotic effects of diclofenac on arteriolar platelet activation and thrombosis in vivo","volume":"7","author":"Struthmann","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2019.01.005","article-title":"Inhibition of platelet function after ocular administration of non-steroidal anti-inflammatory drugs","volume":"175","author":"Falcinelli","year":"2019","journal-title":"Thromb. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13256-019-2097-5","article-title":"Diclofenac-induced thrombotic thrombocytopenic purpura with concomitant complement dysregulation: A case report and review of the literature","volume":"13","author":"Lara","year":"2019","journal-title":"J. Med. Case Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/1024907919845526","article-title":"Recurrent diclofenac-induced acute myocardial infarction: An interesting case with wandering ST-segment elevation","volume":"27","author":"Karakaya","year":"2020","journal-title":"Hong Kong J. Emerg. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ame2.12301","article-title":"Blood coagulation factors and platelet response to drug-induced hepatitis and hepatosis in rats","volume":"6","author":"Korolova","year":"2023","journal-title":"Anim. Models Exp. Med."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Abdel-Rahman, O.N., and Abdel-Baky, E.S. (2021). Hematological and renoprotective effects of folic acid and lentil extract in diclofenac sodium exposed rats. Braz. J. Biol., 83.","DOI":"10.1590\/1519-6984.247360"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"227","DOI":"10.31351\/vol32iss1pp227-236","article-title":"Subchronic effect of different doses ofDiclofenac Sodium on female reproductive system in rats","volume":"32","author":"Salim","year":"2023","journal-title":"Iraqi J. Pharm. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e201178","DOI":"10.1590\/s2175-97902023e201178","article-title":"Organic osmolyte betaine mitigates the deleterious effects of Diclofenac in vivo in wistar albino rats","volume":"59","author":"Basheeruddin","year":"2023","journal-title":"Braz. J. Pharm. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.57187\/s.3535","article-title":"Use of metamizole and other non-opioid analgesics in Switzerland between 2014 and 2019: An observational study using a large health insurance claims database","volume":"154","author":"Gut","year":"2024","journal-title":"Swiss Med. Wkly."},{"key":"ref_73","first-page":"5","article-title":"The effect of tilmicosin and diclofenac sodium combination on cardiac biomarkers in sheep","volume":"26","author":"Ider","year":"2023","journal-title":"Pol. J. Vet. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Rezq, S., Mahmoud, M.F., El-Shazly, A.M., El Raey, M.A., and Sobeh, M. (2021). Anti-Inflammatory, Antipyretic, and Analgesic Properties of Potamogeton perfoliatus Extract: In Vitro and In Vivo Study. Molecules, 26.","DOI":"10.3390\/molecules26164826"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11239-017-1593-y","article-title":"Thromboxane inhibition during concurrent therapy with low-dose aspirin and over-the-counter naproxen sodium","volume":"45","author":"Gurbel","year":"2018","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.thromres.2018.08.012","article-title":"Effects of GS-9876, a novel spleen tyrosine kinase inhibitor, on platelet function and systemic hemostasis","volume":"170","author":"Clarke","year":"2018","journal-title":"Thromb. Res."},{"key":"ref_77","first-page":"e71706","article-title":"A Review of Platelet-Rich Plasma Use in Patients Taking Non-steroidal Anti-inflammatory Drugs for Guideline Development","volume":"16","author":"Leach","year":"2024","journal-title":"Cureus"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/ard.58.4.257","article-title":"Effects of nabumetone compared with naproxen on platelet aggregation in patients with rheumatoid arthritis","volume":"58","author":"Martens","year":"1999","journal-title":"Ann. Rheum. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0609.1984.tb02390.x","article-title":"Effect on platelet aggregation of oral administration of 10 non-steroidal analgesics to humans","volume":"33","author":"Cronberg","year":"1984","journal-title":"Scand. J. Haematol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0049-3848(78)90086-5","article-title":"Effect of three nonsteroidal anti-inflammatory agents on platelet function and prostaglandin synthesis in vitro","volume":"12","author":"McIntyre","year":"1978","journal-title":"Thromb. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"107798","DOI":"10.1016\/j.jece.2022.107798","article-title":"A review of the toxicology presence and removal of ketoprofen through adsorption technology","volume":"10","author":"Georgin","year":"2022","journal-title":"J. Environ. Chem. Eng."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0002-9343(01)00838-5","article-title":"Comparison of the effects of ketoprofen on platelet function in the presence and absence of aspirin","volume":"111","author":"Rosenstein","year":"2001","journal-title":"Am. J. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s002280050189","article-title":"Effects of ketoprofen and ibuprofen on platelet aggregation and prostanoid formation in man","volume":"51","author":"Stichtenoth","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1090-0233(98)80020-8","article-title":"Effect of ketoprofen on PAF-induced bovine platelet aggregation","volume":"155","author":"Gustin","year":"1998","journal-title":"Vet. J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1365-2044.1994.tb04352.x","article-title":"Effect of ketorolac, ketoprofen and nefopam on platelet function","volume":"49","author":"Dordoni","year":"1994","journal-title":"Anaesthesia"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/030006058301100409","article-title":"Effects of Intravenous High Doses of Ketoprofen on Blood Clotting, Bleeding Time and Platelet Aggregation in Man","volume":"11","author":"Gandini","year":"1983","journal-title":"J. Int. Med. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MBC.0b013e3282e38e41","article-title":"Influencing factors of ADP-induced, epinephrine-induced and ristomycin-induced platelet aggregation in dogs","volume":"19","author":"Halmay","year":"2008","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1556\/AVet.55.2007.3.2","article-title":"Evaluation of the effect of ketoprofen and carprofen on platelet function in dogs studied by PFA-100 point-of-care analyser","volume":"55","author":"Halmay","year":"2007","journal-title":"Acta Vet. Hung."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Monteiro, C., Silvestre, S., Duarte, A.P., and Alves, G. (2022). Safety of Non-Steroidal Anti-Inflammatory Drugs in the Elderly: An Analysis of Published Literature and Reports Sent to the Portuguese Pharmacovigilance System. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19063541"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2460\/javma.2002.220.1818","article-title":"Effects of preoperative administration of ketoprofen on whole blood platelet aggregation, buccal mucosal bleeding time, and hematologic indices in dogs undergoing elective ovariohysterectomy","volume":"220","author":"Lemke","year":"2002","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1090-0233(02)00168-5","article-title":"Ketoprofen in the Cat: Pharmacodynamics and Chiral Pharmacokinetics","volume":"165","author":"Lees","year":"2003","journal-title":"Vet. J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF01782978","article-title":"Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDS and Cox 2 inhibitors","volume":"44","author":"Grossman","year":"1995","journal-title":"Inflamm. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"377","DOI":"10.17219\/acem\/37128","article-title":"Effect of Ketoprofen on Lactic Dehydrogenase from Human Platelets","volume":"23","author":"Razi","year":"2014","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Lucarini, L., Durante, M., Sgambellone, S., Lanzi, C., Bigagli, E., Akgul, O., Masini, E., Supuran, C.T., and Carta, F. (2020). Effects of New NSAID-CAI Hybrid Compounds in Inflammation and Lung Fibrosis. Biomolecules, 10.","DOI":"10.3390\/biom10091307"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1213\/01.ANE.0000105866.99259.94","article-title":"Acetylsalicylic Acid, Diclofenac, and Lornoxicam, but Not Rofecoxib, Affect Platelet CD 62 Expression","volume":"98","author":"Blaicher","year":"2004","journal-title":"Anesth. Analg."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1365-2044.2004.03907.x","article-title":"Effect of non-selective, non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors on the PFA-100 closure time","volume":"59","author":"Blaicher","year":"2004","journal-title":"Anaesthesia"},{"key":"ref_97","first-page":"S78","article-title":"Lung inflammatory response syndrome after cardiac-operations and treatment of lornoxicam","volume":"6","author":"Tsakiridis","year":"2014","journal-title":"J. Thorac. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s000110050474","article-title":"The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1\/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro","volume":"48","author":"Berg","year":"1999","journal-title":"Inflamm. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1017\/S0265021508004274","article-title":"Preemptive analgesia by lornoxicam--an NSAID--significantly inhibits perioperative platelet aggregation","volume":"25","author":"Felfernig","year":"2008","journal-title":"Eur. J. Anaesthesiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.egja.2011.12.005","article-title":"Preincisional peritonsillar vs. intravenous lornoxicam for posttonsillectomy analgesia: A clinical and platelet aggregometry comparative study","volume":"28","author":"Sayed","year":"2012","journal-title":"Egypt. J. Anaesth."},{"key":"ref_101","first-page":"573","article-title":"Characterization of etoricoxib, a novel, selective COX-2 inhibitor","volume":"43","author":"Dallob","year":"2003","journal-title":"J. Clin. Pharmacol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2217\/17460816.2.6.545","article-title":"Update on the clinical pharmacology of etoricoxib, a potent cyclooxygenase-2 inhibitor","volume":"2","author":"Cervantes","year":"2007","journal-title":"Future Rheumatol."},{"key":"ref_103","first-page":"265","article-title":"Clinical pharmacology of etoricoxib: A novel selectiveCOX2 inhibitor","volume":"4","author":"Patrignani","year":"2003","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_104","first-page":"1028","article-title":"Etoricoxib Induced Thrombotic Thrombocytopenic Purpura","volume":"1","author":"Mohd","year":"2020","journal-title":"Int. J. Fam. Med. Prim. Care"},{"key":"ref_105","unstructured":"(2025, May 07). PubChem Niflumic Acid, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/4488."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V108.11.3909.3909","article-title":"Effects of Niflumic Acid on Thrombocytic Cytoplasmic Free Calcium and Platelet Aggregation in Patients with Diabetes Mellitus","volume":"108","author":"Nie","year":"2006","journal-title":"Blood"},{"key":"ref_107","unstructured":"\u041f\u0435\u0440\u043b\u043e\u0432\u0438\u0447, \u0413.\u041b., \u041c\u0430\u043d\u0438\u043d, \u0410.\u041d., \u041c\u0430\u043d\u0438\u043d, \u041d.\u0413., \u0421\u0443\u0440\u043e\u0432, \u0410.\u041e., and \u0412\u043e\u0440\u043e\u043d\u0438\u043d, \u0410.\u041f. (2014). Cocrystalline Form of Niflumic Acid with Isonicotinamide ot Caffeine. (Patent No. RU2536484C1)."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/sj.bjp.0705571","article-title":"The Cl\u2212 channel blocker niflumic acid releases Ca2+ from an intracellular store in rat pulmonary artery smooth muscle cells","volume":"140","author":"Cruickshank","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0024-3205(98)00457-3","article-title":"Dual effects of nimesulide, a COX-2 inhibitor, in human platelets","volume":"63","author":"Saeed","year":"1998","journal-title":"Life Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.bjp.0706711","article-title":"Biological properties of a specific G\u03b1q\/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress","volume":"148","author":"Uemura","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1163\/156856001300248425","article-title":"Involvement of cyclooxygenase, phospholipase C and MAP kinase pathways in human platelet aggregation mediated by the synergistic interaction of adrenaline and PAF","volume":"9","author":"Saeed","year":"2001","journal-title":"Inflammopharmacology"},{"key":"ref_112","first-page":"1110","article-title":"Inhibition of the production of platelet activating factor and of leukotriene B4 in activated neutrophils by nimesulide due to an elevation of intracellular cyclic adenosine monophosphate","volume":"45","author":"Tool","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2165\/00003495-199300461-00011","article-title":"Nimesulide inhibits platelet-activating factor synthesis in activated human neutrophils","volume":"46","author":"Verhoeven","year":"1993","journal-title":"Drugs"},{"key":"ref_114","unstructured":"(2025, May 07). Drug Interaction Report: Allopurinol, Warfarin. Available online: https:\/\/www.drugs.com\/drug-interactions\/allopurinol-with-warfarin-127-0-2311-0.html."},{"key":"ref_115","first-page":"63","article-title":"A study of platelet aggregation and adhesion in gout","volume":"1","author":"Macfarlane","year":"1983","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_116","first-page":"143","article-title":"Uric acid levels and platelet function in humans. An in-vivo ex-vivo study","volume":"1","author":"Ciompi","year":"1983","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/gut.44.2.203","article-title":"The role of xanthine oxidase in platelet activating factor induced intestinal injury in the rat","volume":"44","author":"Qu","year":"1999","journal-title":"Gut"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1159\/000529149","article-title":"Comparison of Prasugrel and Clopidogrel in Thrombotic Stroke Patients with Risk Factors for Ischemic Stroke Recurrence: An Integrated Analysis of PRASTRO-I, PRASTRO-II, and PRASTRO-III","volume":"52","author":"Kitazono","year":"2023","journal-title":"Cerebrovasc. Dis."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Yang, Y., Guo, L., Shen, D., Dong, Z., Lin, Y., Liu, H., Wei, Y., and Zhang, B. (2024). Effect of ticagrelor versus clopidogrel after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome\u2014Propensity score matching analysis. BMC Cardiovasc. Disord., 24.","DOI":"10.1186\/s12872-023-03659-0"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Chi, G., AlKhalfan, F., Lee, J.J., Montazerin, S.M., Fitzgerald, C., Korjian, S., Omar, W., Barnathan, E., Plotnikov, A., and Gibson, C.M. (2024). Factors associated with early, late, and very late stent thrombosis among patients with acute coronary syndrome undergoing coronary stent placement: Analysis from the ATLAS ACS 2-TIMI 51 trial. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1269011"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4274\/tjh.galenos.2024.2024.0043","article-title":"Assessment of Aspirin and Clopidogrel Resistance in Patients Undergoing Cardiovascular Surgery: A Single-Center Cross- Sectional Study","volume":"41","author":"Tak","year":"2024","journal-title":"Turk. J. Hematol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"123118","DOI":"10.1016\/j.jns.2024.123118","article-title":"von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapy","volume":"463","author":"Smith","year":"2024","journal-title":"J. Neurol. Sci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1001\/jamacardio.2018.4171","article-title":"Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial","volume":"4","author":"Olivier","year":"2019","journal-title":"JAMA Cardiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"e027790","DOI":"10.1161\/JAHA.122.027790","article-title":"Predicting Arterial Thrombotic Events Following Peripheral Revascularization Using Objective Viscoelastic Data","volume":"12","author":"Majumdar","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_125","first-page":"1019","article-title":"State of the art paper Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease","volume":"9","author":"Gluba","year":"2013","journal-title":"Arch. Med. Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"03000605221081725","DOI":"10.1177\/03000605221081725","article-title":"Long-term effects of baseline on-treatment platelet reactivity in patients with acute coronary syndrome and thrombocytopenia undergoing percutaneous coronary intervention","volume":"50","author":"Liu","year":"2022","journal-title":"J. Int. Med. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood.2021013097","article-title":"Platelet ACKR3\/CXCR7 favors antiplatelet lipids over an atherothrombotic lipidome and regulates thromboinflammation","volume":"139","author":"Cebo","year":"2022","journal-title":"Blood"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Sikora, J., Pstr\u0105gowski, K., Karczmarska-W\u00f3dzka, A., Wszelaki, P., Buszko, K., and W\u0142odarczyk, Z. (2024). Impact of Levosimendan and Its Metabolites on Platelet Activation Mechanisms in Patients during Antiplatelet Therapy\u2014Pilot Study. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031824"},{"key":"ref_129","first-page":"2309","article-title":"Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: A hypothesis-generating study","volume":"11","author":"Mazereeuw","year":"2015","journal-title":"NDT"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e030058","DOI":"10.1161\/JAHA.123.030058","article-title":"Genetic-Guided Pharmacotherapy for Coronary Artery Disease: A Systematic and Critical Review of Economic Evaluations","volume":"13","author":"Lim","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.4244\/EIJ-D-21-00165","article-title":"A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post hoc analysis of the RE-DUAL PCI trial","volume":"18","author":"Zwart","year":"2022","journal-title":"EuroIntervention"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"100612","DOI":"10.1016\/j.imu.2021.100612","article-title":"A neural system dynamics modeling platform and its applications in randomized controlled trial data analysis","volume":"24","author":"Hamid","year":"2021","journal-title":"Inform. Med. Unlocked"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1757-1626-3-68","article-title":"In-stent thrombosis after 68 months of implantation inspite of continuous dual antiplatelet therapy: A case report","volume":"3","author":"Nagrani","year":"2010","journal-title":"Cases J."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/aas.14157","article-title":"Thromboembolic and bleeding events in ICU patients with COVID-19: A nationwide, observational study","volume":"67","author":"Russell","year":"2023","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/jvim.16727","article-title":"Synergistic inhibitory effects of clopidogrel and rivaroxaban on platelet function and platelet-dependent thrombin generation in cats","volume":"37","author":"Lo","year":"2023","journal-title":"J. Vet. Intern. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1002\/cpz1.711","article-title":"Evaluation of the Efficacy and Safety of Antiplatelet Therapeutics in Rabbits","volume":"3","author":"Kuszynski","year":"2023","journal-title":"Curr. Protoc."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/bph.15667","article-title":"Is platelet responsiveness to clopidogrel attenuated in overweight or obese patients and why? A reverse translational study in mice","volume":"179","author":"Jiang","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/jth.13911","article-title":"Inflammation and thrombosis: Roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis","volume":"16","author":"Iba","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/1755-5922.12233","article-title":"Platelet activating factor: A potential biomarker in acute coronary syndrome?","volume":"35","author":"Varghese","year":"2017","journal-title":"Cardiovasc. Ther."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e033791","DOI":"10.1161\/JAHA.123.033791","article-title":"CYP2C19 Genotype Is Associated with Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention","volume":"13","author":"Tunehag","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s40119-024-00348-7","article-title":"Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago","volume":"13","author":"Jones","year":"2024","journal-title":"Cardiol. Ther."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e026482","DOI":"10.1161\/JAHA.122.026482","article-title":"On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients with Diabetes Mellitus: Two-Year Results From ADAPT-DES","volume":"12","author":"Shahim","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0037-1614133","article-title":"Identification and biological activity of the active metabolite of clopidogrel","volume":"84","author":"Savi","year":"2000","journal-title":"Thromb. Haemost."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for Coronary Stenting","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/sj.bjp.0702276","article-title":"Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro","volume":"126","author":"Weber","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1096\/fj.07-8506com","article-title":"Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man","volume":"22","author":"Hinz","year":"2008","journal-title":"FASEB J."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1163\/156856001300248407","article-title":"Inhibition of prostaglandin synthesis in intact cells by paracetamol (acetaminophen)","volume":"9","author":"Graham","year":"2001","journal-title":"Inflammopharmacology"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"23259671221088820","DOI":"10.1177\/23259671221088820","article-title":"A Systematic Review on the Effect of Common Medications on Platelet Count and Function: Which Medications Should Be Stopped Before Getting a Platelet-Rich Plasma Injection?","volume":"10","author":"Kao","year":"2022","journal-title":"Orthop. J. Sports Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/STROKEAHA.115.012091","article-title":"Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients with Recent Ischemic Stroke","volume":"47","author":"Sissani","year":"2016","journal-title":"Stroke"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin","volume":"345","author":"Reilly","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF02857774","article-title":"Inhibition of platelet aggregation by colchicine, thiocolchicine, and their phenolic and glucosidic congeners","volume":"10","author":"Brossi","year":"1987","journal-title":"Arch. Pharm. Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1055\/s-0042-1749660","article-title":"Colchicine as a Modulator of Platelet Function: A Systematic Review","volume":"48","author":"Reddel","year":"2022","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_153","first-page":"219","article-title":"Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: Randomized crossover trial","volume":"46","author":"Punda","year":"2005","journal-title":"Croat. Med. J."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/bcp.12404","article-title":"Effect of \u03b2-blockers on platelet aggregation: A systematic review and meta-analysis","volume":"78","author":"Bonten","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1476-5381.1983.tb10005.x","article-title":"Platelet \u03b2-adrenoceptors","volume":"79","author":"Kerry","year":"1983","journal-title":"Br. J. Pharmacol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ihj.2013.04.019","article-title":"Epidemiology of cardioprotective pharmacological agent use in stable coronary heart disease","volume":"65","author":"Sharma","year":"2013","journal-title":"Indian Heart J."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/BF00182709","article-title":"The deltoid muscle: An electromyographical analysis of its activity in arm abduction in various body postures","volume":"16","author":"Michiels","year":"1992","journal-title":"Int. Orthop."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0021-5198(19)52559-8","article-title":"Drug-induced inhibition of guinea pig platelet aggregation unrelated to their \u03b2-adrenolytic actions","volume":"33","author":"Iwamura","year":"1983","journal-title":"Jpn. J. Pharmacol."},{"key":"ref_159","first-page":"261","article-title":"The role of prostaglandins in the effect of beta-blockers on stimulated blood platelets","volume":"37","year":"1991","journal-title":"Vnitr. Lek."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0952-3278(89)90154-3","article-title":"Influence of propranolol on platelet aggregation and thromboxane B2 production from platelet-rich plasma and whole blood","volume":"36","author":"Anfossi","year":"1989","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1182\/blood.V49.2.185.185","article-title":"Effect of propranolol on platelet function","volume":"49","author":"Weksler","year":"1977","journal-title":"Blood"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF00635893","article-title":"Effect of metoprolol and propranolol on platelet aggregation and cAMP level in hypertensive patients","volume":"29","author":"Winther","year":"1986","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1074248415581175","article-title":"Influence of Different \u03b2-Blockers on Platelet Aggregation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy","volume":"21","author":"Ignjatovic","year":"2016","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF00280128","article-title":"Metoprolol does not reduce platelet aggregability during sympatho-adrenal stimulation","volume":"42","author":"Larsson","year":"1992","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_165","first-page":"51","article-title":"Thrombolytic activity of beta-adrenolytic drug, sotalol","volume":"49","author":"Korbut","year":"1998","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Premuzic Mestrovic, I., Smoday, I.M., Kalogjera, L., Krezic, I., Zizek, H., Vranes, H., Vukovic, V., Oroz, K., Skorak, I., and Brizic, I. (2023). Antiarrhythmic Sotalol, Occlusion\/Occlusion-like Syndrome in Rats, and Stable Gastric Pentadecapeptide BPC 157 Therapy. Pharmaceuticals, 16.","DOI":"10.3390\/ph16070977"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5551\/jat.14.31","article-title":"Platelet aggregability in patients with hypertension treated with angiotensin II type 1 receptor blockers","volume":"14","author":"Sato","year":"2007","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_168","first-page":"70A","article-title":"P-86: Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients","volume":"14","author":"Fogari","year":"2003","journal-title":"Am. J. Hypertens."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3317\/jraas.2000.022","article-title":"Losartan inhibits in vitro platelet activation: Comparison with candesartan and valsartan","volume":"1","author":"Zalba","year":"2000","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00005344-200104000-00007","article-title":"Inhibition of Platelet Activation in Stroke-Prone Spontaneously Hypertensive Rats: Comparison of Losartan, Candesartan, and Valsartan","volume":"37","author":"Rico","year":"2001","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1139\/y06-087","article-title":"Differential effects of losartan and candesartan on vasoconstrictor responses in the ratThis paper is one of a selection of papers published in this Special Issue, entitled The Cellular and Molecular Basis of Cardiovascular Dysfunction, Dhalla 70th Birthday Tribute","volume":"85","author":"Nossaman","year":"2007","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"H2306","DOI":"10.1152\/ajpheart.00601.2006","article-title":"Angiotensin II type 1 receptor signaling contributes to platelet-leukocyte-endothelial cell interactions in the cerebral microvasculature","volume":"292","author":"Ishikawa","year":"2007","journal-title":"Am. J. Physiol. -Heart Circ. Physiol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1468-1331.2007.01847.x","article-title":"Modification of neutrophil adhesion to human endothelial cell line in acute ischemic stroke by dipyridamole and candesartan","volume":"14","author":"Hallevi","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s11845-017-1580-5","article-title":"The effect of candesartan on pentraxin-3 plasma levels as marker of endothelial dysfunction in patients with essential arterial hypertension","volume":"186","author":"Buda","year":"2017","journal-title":"Ir. J. Med. Sci."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5414\/CP202503","article-title":"Evaluation of the effect of angiotensin converting enzyme inhibitors and angiotensin receptors blockers on aspirin antiplatelet effect","volume":"54","author":"Alzoubi","year":"2016","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2165\/00003495-199856050-00013","article-title":"Candesartan cilexetil. A review of its use in essential hypertension","volume":"56","author":"McClellan","year":"1998","journal-title":"Drugs"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0006-2952(02)01074-2","article-title":"Predicting plasma protein binding of drugs: A new approach","volume":"64","author":"Kratochwil","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/med.10039","article-title":"In silico prediction of drug-binding strengths to human serum albumin","volume":"23","author":"Colmenarejo","year":"2003","journal-title":"Med. Res. Rev."},{"key":"ref_179","unstructured":"Malinin, A., Serebruany, V.L., and Webb, R.L. (2003). Use of Valsartan ot Its Metabolite to Inhibit Platelet Aggregation. (Patent No. WO2003094915A1)."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00005344-200405000-00010","article-title":"Effects of Valsartan and Valeryl 4-Hydroxy Valsartan on Human Platelets: A Possible Additional Mechanism for Clinical Benefits","volume":"43","author":"Serebruany","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ahj.2005.03.001","article-title":"Valsartan inhibits platelet activity at different doses in mild to moderate hypertensives: Valsartan Inhibits Platelets (VIP) trial","volume":"151","author":"Serebruany","year":"2006","journal-title":"Am. Heart J."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0366-6999.149185","article-title":"Valsartan Decreases Platelet Activity and Arterial Thrombotic Events in Elderly Patients with Hypertension","volume":"128","author":"Wu","year":"2015","journal-title":"Chin. Med. J."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/MJT.0b013e31826915ab","article-title":"Effect of Aliskiren and Valsartan Combination Versus Aliskiren Monotherapy on Hemostatic Biomarkers in Hypertensive Diabetics: Aliskiren and Valsartan Impact in Diabetics Pilot Trial","volume":"21","author":"Serebruany","year":"2014","journal-title":"Am. J. Ther."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1161\/01.HYP.0000034745.98129.EC","article-title":"Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release","volume":"40","author":"Kalinowski","year":"2002","journal-title":"Hypertension"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/ndt\/16.suppl_1.45","article-title":"Angiotensin II AT1 receptor antagonists and platelet activation","volume":"16","author":"Rico","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.HYP.37.3.961","article-title":"Effect of Valsartan on Angiotensin II\u2013Induced Plasminogen Activator Inhibitor-1 Biosynthesis in Arterial Smooth Muscle Cells","volume":"37","author":"Sironi","year":"2001","journal-title":"Hypertension"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/FJC.0b013e31805751d3","article-title":"Effect of Fluvastatin and Valsartan, Alone and in Combination, on Postprandial Vascular Inflammation and Fibrinolytic Activity in Patients with Essential Hypertension","volume":"50","author":"Liu","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1742-1241.2006.01063.x","article-title":"Platelet inhibition beyond conventional antiplatelet agents: Expanding role of angiotensin receptor blockers, statins and selective serotonin reuptake inhibitors","volume":"60","author":"Malinin","year":"2006","journal-title":"Int. J. Clin. Pract."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/j.1552-4604.1997.tb04783.x","article-title":"Protein binding in plasma of valsartan, a new angiotensin II receptor antagonist","volume":"37","author":"Colussi","year":"1997","journal-title":"J. Clin. Pharmacol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"5575545","DOI":"10.1155\/2021\/5575545","article-title":"Pleiotropic Properties of Valsartan: Do They Result from the Antiglycooxidant Activity? Literature Review and In Vitro Study","volume":"2021","author":"Mil","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Tomczyk, M.D., Matczak, K., Denel-Bobrowska, M., Dzido, G., Kubicka, A., Gendosz de Carrillo, D., Cicho\u0144, T., Golec, M., Powieczko, B., and Rzetelny, W. (2025). Combining Sulfonylureas with Anticancer Drugs: Evidence of Synergistic Efficacy with Doxorubicin In Vitro and In Vivo. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26041429"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Tsoupras, A., Gkika, D.A., Siadimas, I., Christodoulopoulos, I., Efthymiopoulos, P., and Kyzas, G.Z. (2024). The Multifaceted Effects of Non-Steroidal and Non-Opioid Anti-Inflammatory and Analgesic Drugs on Platelets: Current Knowledge, Limitations, and Future Perspectives. Pharmaceuticals, 17.","DOI":"10.3390\/ph17050627"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI27291","article-title":"Biological basis for the cardiovascular consequences of COX-2 inhibition: Therapeutic challenges and opportunities","volume":"116","author":"Grosser","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(99)10365-9","article-title":"Angiotensin II receptor antagonists","volume":"355","author":"Burnier","year":"2000","journal-title":"Lancet"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1182\/blood.V39.2.187.187","article-title":"Thrombocytopathia Due to Abnormalities in Platelet Release Reaction\u2014Studies on Six Unrelated Patients","volume":"39","author":"Weiss","year":"1972","journal-title":"Blood"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2337\/diab.35.7.818","article-title":"Studies on Mechanisms Involved in Hypoglycemia-Induced Platelet Activation","volume":"35","author":"Trovati","year":"1986","journal-title":"Diabetes"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1413\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:22:58Z","timestamp":1760034178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":197,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["medicina61081413"],"URL":"https:\/\/doi.org\/10.3390\/medicina61081413","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]}}}